Regulation of K-Cl cotransport by Syk and Src protein tyrosine kinases in deoxygenated sickle cells

Protein tyrosine kinases (PTK) of the Src family are thought to suppress K-Cl cotransport (KCC) activity via negative regulation of protein phosphatases. However, some PTK inhibitors reduce KCC activity, suggesting opposite regulation by different PTK families. We have reported previously that deoxy...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pflügers Archiv 2003-05, Vol.446 (2), p.232-238
Hauptverfasser: Merciris, P, Claussen, W J, Joiner, C H, Giraud, F
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 238
container_issue 2
container_start_page 232
container_title Pflügers Archiv
container_volume 446
creator Merciris, P
Claussen, W J
Joiner, C H
Giraud, F
description Protein tyrosine kinases (PTK) of the Src family are thought to suppress K-Cl cotransport (KCC) activity via negative regulation of protein phosphatases. However, some PTK inhibitors reduce KCC activity, suggesting opposite regulation by different PTK families. We have reported previously that deoxygenation of sickle cells stimulates KCC and activates Syk (a Syk family PTK), but not Lyn (an Src family PTK). In this study the same results were obtained when PTK activities were measured under the conditions used to measure KCC activity and which prevent any change in intracellular [Mg(2+)]. Methyl-2,5-dihydroxycinnamate (DHC), a PTK inhibitor, was more selective for Syk than Lyn, while staurosporine (ST), a broad-specificity protein kinase inhibitor, inhibited Lyn more than Syk. Deoxygenation or 4-amino-5-(4-chlorophenyl)-7-( t-butyl)pyrazolo[3,4- d] pyrimidine (pp2, a specific Src inhibitor) stimulated KCC independently. These effects were not additive and were inhibited by DHC. In contrast, ST-induced KCC activation was resistant to DHC, suggesting a different pathway of activation. Overall, these data indicate that Syk activity is required for KCC activation, either induced by deoxygenation of sickle cells, or mediated by Src inhibition in oxygenated cells, and that Syk and Src PTKs exert opposing and interconnected regulatory effects on the activity of the transporter.
doi_str_mv 10.1007/s00424-003-1025-z
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_763372146</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2186129021</sourcerecordid><originalsourceid>FETCH-LOGICAL-c324t-fde1d9feab0cc6ef6bb023d90a5a0b94c7c23fdfa9578bbcab988214f5dcdd73</originalsourceid><addsrcrecordid>eNpFkFtLAzEQhYMotlZ_gC8SfI9Okr0-SvGGBcH2PeRatt3u1iQLbn-9kRZ8Gpg558zMh9AthQcKUD4GgIxlBIATCiwnhzM0pRlnhAHl52iaBpQUZVFN0FUIGwBgWcUu0YSykte0oFOkv-x6aGVs-g73Dn-QeYt1H73swr73EasRL8ctlp3BS6_x3vfRNh2Oo-9D01m8bToZbMCpZ2z_M65tJ6M1ODR621qsbduGa3ThZBvszanO0OrleTV_I4vP1_f504JozrJInLHU1M5KBVoX1hVKAeOmBplLUHWmS824M07WeVkppaWqq4rRzOVGG1PyGbo_xqYjvwcbotj0g-_SRlEWnJdJWiQRPYp0eiB468TeNzvpR0FB_EEVR6gisRN_UMUhee5OwYPaWfPvOFHkv-xNdNE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>763372146</pqid></control><display><type>article</type><title>Regulation of K-Cl cotransport by Syk and Src protein tyrosine kinases in deoxygenated sickle cells</title><source>MEDLINE</source><source>Springer Online Journals Complete</source><creator>Merciris, P ; Claussen, W J ; Joiner, C H ; Giraud, F</creator><creatorcontrib>Merciris, P ; Claussen, W J ; Joiner, C H ; Giraud, F</creatorcontrib><description>Protein tyrosine kinases (PTK) of the Src family are thought to suppress K-Cl cotransport (KCC) activity via negative regulation of protein phosphatases. However, some PTK inhibitors reduce KCC activity, suggesting opposite regulation by different PTK families. We have reported previously that deoxygenation of sickle cells stimulates KCC and activates Syk (a Syk family PTK), but not Lyn (an Src family PTK). In this study the same results were obtained when PTK activities were measured under the conditions used to measure KCC activity and which prevent any change in intracellular [Mg(2+)]. Methyl-2,5-dihydroxycinnamate (DHC), a PTK inhibitor, was more selective for Syk than Lyn, while staurosporine (ST), a broad-specificity protein kinase inhibitor, inhibited Lyn more than Syk. Deoxygenation or 4-amino-5-(4-chlorophenyl)-7-( t-butyl)pyrazolo[3,4- d] pyrimidine (pp2, a specific Src inhibitor) stimulated KCC independently. These effects were not additive and were inhibited by DHC. In contrast, ST-induced KCC activation was resistant to DHC, suggesting a different pathway of activation. Overall, these data indicate that Syk activity is required for KCC activation, either induced by deoxygenation of sickle cells, or mediated by Src inhibition in oxygenated cells, and that Syk and Src PTKs exert opposing and interconnected regulatory effects on the activity of the transporter.</description><identifier>ISSN: 0031-6768</identifier><identifier>EISSN: 1432-2013</identifier><identifier>DOI: 10.1007/s00424-003-1025-z</identifier><identifier>PMID: 12739161</identifier><language>eng</language><publisher>Germany: Springer Nature B.V</publisher><subject>Dose-Response Relationship, Drug ; Enzyme Precursors - antagonists &amp; inhibitors ; Enzyme Precursors - metabolism ; Hemoglobin, Sickle - metabolism ; Humans ; Intracellular Signaling Peptides and Proteins ; K Cl- Cotransporters ; Protein-Tyrosine Kinases - antagonists &amp; inhibitors ; Protein-Tyrosine Kinases - metabolism ; src-Family Kinases - antagonists &amp; inhibitors ; src-Family Kinases - metabolism ; Staurosporine - pharmacology ; Syk Kinase ; Symporters - metabolism</subject><ispartof>Pflügers Archiv, 2003-05, Vol.446 (2), p.232-238</ispartof><rights>Springer-Verlag 2003</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c324t-fde1d9feab0cc6ef6bb023d90a5a0b94c7c23fdfa9578bbcab988214f5dcdd73</citedby><cites>FETCH-LOGICAL-c324t-fde1d9feab0cc6ef6bb023d90a5a0b94c7c23fdfa9578bbcab988214f5dcdd73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27929,27930</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12739161$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Merciris, P</creatorcontrib><creatorcontrib>Claussen, W J</creatorcontrib><creatorcontrib>Joiner, C H</creatorcontrib><creatorcontrib>Giraud, F</creatorcontrib><title>Regulation of K-Cl cotransport by Syk and Src protein tyrosine kinases in deoxygenated sickle cells</title><title>Pflügers Archiv</title><addtitle>Pflugers Arch</addtitle><description>Protein tyrosine kinases (PTK) of the Src family are thought to suppress K-Cl cotransport (KCC) activity via negative regulation of protein phosphatases. However, some PTK inhibitors reduce KCC activity, suggesting opposite regulation by different PTK families. We have reported previously that deoxygenation of sickle cells stimulates KCC and activates Syk (a Syk family PTK), but not Lyn (an Src family PTK). In this study the same results were obtained when PTK activities were measured under the conditions used to measure KCC activity and which prevent any change in intracellular [Mg(2+)]. Methyl-2,5-dihydroxycinnamate (DHC), a PTK inhibitor, was more selective for Syk than Lyn, while staurosporine (ST), a broad-specificity protein kinase inhibitor, inhibited Lyn more than Syk. Deoxygenation or 4-amino-5-(4-chlorophenyl)-7-( t-butyl)pyrazolo[3,4- d] pyrimidine (pp2, a specific Src inhibitor) stimulated KCC independently. These effects were not additive and were inhibited by DHC. In contrast, ST-induced KCC activation was resistant to DHC, suggesting a different pathway of activation. Overall, these data indicate that Syk activity is required for KCC activation, either induced by deoxygenation of sickle cells, or mediated by Src inhibition in oxygenated cells, and that Syk and Src PTKs exert opposing and interconnected regulatory effects on the activity of the transporter.</description><subject>Dose-Response Relationship, Drug</subject><subject>Enzyme Precursors - antagonists &amp; inhibitors</subject><subject>Enzyme Precursors - metabolism</subject><subject>Hemoglobin, Sickle - metabolism</subject><subject>Humans</subject><subject>Intracellular Signaling Peptides and Proteins</subject><subject>K Cl- Cotransporters</subject><subject>Protein-Tyrosine Kinases - antagonists &amp; inhibitors</subject><subject>Protein-Tyrosine Kinases - metabolism</subject><subject>src-Family Kinases - antagonists &amp; inhibitors</subject><subject>src-Family Kinases - metabolism</subject><subject>Staurosporine - pharmacology</subject><subject>Syk Kinase</subject><subject>Symporters - metabolism</subject><issn>0031-6768</issn><issn>1432-2013</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNpFkFtLAzEQhYMotlZ_gC8SfI9Okr0-SvGGBcH2PeRatt3u1iQLbn-9kRZ8Gpg558zMh9AthQcKUD4GgIxlBIATCiwnhzM0pRlnhAHl52iaBpQUZVFN0FUIGwBgWcUu0YSykte0oFOkv-x6aGVs-g73Dn-QeYt1H73swr73EasRL8ctlp3BS6_x3vfRNh2Oo-9D01m8bToZbMCpZ2z_M65tJ6M1ODR621qsbduGa3ThZBvszanO0OrleTV_I4vP1_f504JozrJInLHU1M5KBVoX1hVKAeOmBplLUHWmS824M07WeVkppaWqq4rRzOVGG1PyGbo_xqYjvwcbotj0g-_SRlEWnJdJWiQRPYp0eiB468TeNzvpR0FB_EEVR6gisRN_UMUhee5OwYPaWfPvOFHkv-xNdNE</recordid><startdate>200305</startdate><enddate>200305</enddate><creator>Merciris, P</creator><creator>Claussen, W J</creator><creator>Joiner, C H</creator><creator>Giraud, F</creator><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7TK</scope><scope>7TS</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope></search><sort><creationdate>200305</creationdate><title>Regulation of K-Cl cotransport by Syk and Src protein tyrosine kinases in deoxygenated sickle cells</title><author>Merciris, P ; Claussen, W J ; Joiner, C H ; Giraud, F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c324t-fde1d9feab0cc6ef6bb023d90a5a0b94c7c23fdfa9578bbcab988214f5dcdd73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Dose-Response Relationship, Drug</topic><topic>Enzyme Precursors - antagonists &amp; inhibitors</topic><topic>Enzyme Precursors - metabolism</topic><topic>Hemoglobin, Sickle - metabolism</topic><topic>Humans</topic><topic>Intracellular Signaling Peptides and Proteins</topic><topic>K Cl- Cotransporters</topic><topic>Protein-Tyrosine Kinases - antagonists &amp; inhibitors</topic><topic>Protein-Tyrosine Kinases - metabolism</topic><topic>src-Family Kinases - antagonists &amp; inhibitors</topic><topic>src-Family Kinases - metabolism</topic><topic>Staurosporine - pharmacology</topic><topic>Syk Kinase</topic><topic>Symporters - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Merciris, P</creatorcontrib><creatorcontrib>Claussen, W J</creatorcontrib><creatorcontrib>Joiner, C H</creatorcontrib><creatorcontrib>Giraud, F</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Physical Education Index</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><jtitle>Pflügers Archiv</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Merciris, P</au><au>Claussen, W J</au><au>Joiner, C H</au><au>Giraud, F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Regulation of K-Cl cotransport by Syk and Src protein tyrosine kinases in deoxygenated sickle cells</atitle><jtitle>Pflügers Archiv</jtitle><addtitle>Pflugers Arch</addtitle><date>2003-05</date><risdate>2003</risdate><volume>446</volume><issue>2</issue><spage>232</spage><epage>238</epage><pages>232-238</pages><issn>0031-6768</issn><eissn>1432-2013</eissn><abstract>Protein tyrosine kinases (PTK) of the Src family are thought to suppress K-Cl cotransport (KCC) activity via negative regulation of protein phosphatases. However, some PTK inhibitors reduce KCC activity, suggesting opposite regulation by different PTK families. We have reported previously that deoxygenation of sickle cells stimulates KCC and activates Syk (a Syk family PTK), but not Lyn (an Src family PTK). In this study the same results were obtained when PTK activities were measured under the conditions used to measure KCC activity and which prevent any change in intracellular [Mg(2+)]. Methyl-2,5-dihydroxycinnamate (DHC), a PTK inhibitor, was more selective for Syk than Lyn, while staurosporine (ST), a broad-specificity protein kinase inhibitor, inhibited Lyn more than Syk. Deoxygenation or 4-amino-5-(4-chlorophenyl)-7-( t-butyl)pyrazolo[3,4- d] pyrimidine (pp2, a specific Src inhibitor) stimulated KCC independently. These effects were not additive and were inhibited by DHC. In contrast, ST-induced KCC activation was resistant to DHC, suggesting a different pathway of activation. Overall, these data indicate that Syk activity is required for KCC activation, either induced by deoxygenation of sickle cells, or mediated by Src inhibition in oxygenated cells, and that Syk and Src PTKs exert opposing and interconnected regulatory effects on the activity of the transporter.</abstract><cop>Germany</cop><pub>Springer Nature B.V</pub><pmid>12739161</pmid><doi>10.1007/s00424-003-1025-z</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0031-6768
ispartof Pflügers Archiv, 2003-05, Vol.446 (2), p.232-238
issn 0031-6768
1432-2013
language eng
recordid cdi_proquest_journals_763372146
source MEDLINE; Springer Online Journals Complete
subjects Dose-Response Relationship, Drug
Enzyme Precursors - antagonists & inhibitors
Enzyme Precursors - metabolism
Hemoglobin, Sickle - metabolism
Humans
Intracellular Signaling Peptides and Proteins
K Cl- Cotransporters
Protein-Tyrosine Kinases - antagonists & inhibitors
Protein-Tyrosine Kinases - metabolism
src-Family Kinases - antagonists & inhibitors
src-Family Kinases - metabolism
Staurosporine - pharmacology
Syk Kinase
Symporters - metabolism
title Regulation of K-Cl cotransport by Syk and Src protein tyrosine kinases in deoxygenated sickle cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-15T13%3A01%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Regulation%20of%20K-Cl%20cotransport%20by%20Syk%20and%20Src%20protein%20tyrosine%20kinases%20in%20deoxygenated%20sickle%20cells&rft.jtitle=Pfl%C3%BCgers%20Archiv&rft.au=Merciris,%20P&rft.date=2003-05&rft.volume=446&rft.issue=2&rft.spage=232&rft.epage=238&rft.pages=232-238&rft.issn=0031-6768&rft.eissn=1432-2013&rft_id=info:doi/10.1007/s00424-003-1025-z&rft_dat=%3Cproquest_cross%3E2186129021%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=763372146&rft_id=info:pmid/12739161&rfr_iscdi=true